[HTML][HTML] Chick chorioallantoic membrane (CAM) assays as a model of patient-derived xenografts from circulating cancer stem cells (cCSCs) in breast cancer patients

M Pizon, D Schott, U Pachmann, R Schobert, M Pizon… - Cancers, 2022 - mdpi.com
Simple Summary Circulating cancer cells—and in particular their very rare subpopulation,
circulating cancer stem cells (cCSCs)—are responsible for recurrence and metastasis. In …

[PDF][PDF] Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer …

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2008 - laborpachmann.de
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

[PDF][PDF] Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer …

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2008 - researchgate.net
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients.

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Circulating cancer cells—and in particular their very rare
subpopulation, circulating cancer stem cells (cCSCs)—are responsible for recurrence and …

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2022 - search.proquest.com
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients.

M Pizon, D Schott, U Pachmann, R Schobert… - Cancers, 2022 - europepmc.org
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

[HTML][HTML] Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer …

M Pizon, D Schott, U Pachmann, R Schobert, M Pizon… - Cancers, 2022 - ncbi.nlm.nih.gov
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

[PDF][PDF] Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer …

M Pizon, D Schott, U Pachmann, R Schobert… - …, 2008 - researchgate.net
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients.

M Pizon, D Schott, U Pachmann, R Schobert… - Cancers, 2022 - europepmc.org
Background: cCSCs are a small subset of circulating tumor cells with cancer stem cell
features: resistance to cancer treatments and the capacity for generating metastases. PDX …